GrowingStockReport.com

NASDAQ Decliners Watch List: Amgen Inc. (NASDAQ:AMGN) and MannKind Corp. (NASDAQ:MNKD) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 06/28/2013 -- Growing Stock Report expands its NASDAQ Decliners Watch List adding Amgen Inc. (NASDAQ:AMGN) and MannKind Corp. (NASDAQ:MNKD).

Amgen Inc. (NASDAQ:AMGN) a biotechnology medicines company that engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada closed down in its previous session (-0.33%) on 2,465,320 shares traded. Amgen Inc. (NASDAQ:AMGN) is currently up (+38.18%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Amgen Inc. (NASDAQ:AMGN)

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed down in its previous session (-2.03%) on 4,880,203 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently down (-20.22%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com